By Counterforce Health Team in Filsuvez (birch triterpenes topical gel) —

How to Get Filsuvez Covered by Humana in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Filsuvez Covered by Humana in Washington

Humana Medicare Advantage plans require prior authorization for Filsuvez (birch triterpenes topical gel) to treat confirmed dystrophic or junctional epidermolysis bullosa in patients ≥6 months old. Success requires genetic testing results (COL7A1, LAMA3), wound documentation (10-50 cm²), and failed prior treatments. Submit electronically via Humana's provider portal for fastest approval (95% responded in 1 business day). If denied, Washington's external review through the Office of the Insurance Commissioner provides strong patient protections within 180 days.

First step today: Contact your dermatologist to gather genetic testing results and prior treatment failure documentation—these are essential for PA approval.

Table of Contents

  1. What This Guide Covers
  2. Before You Start: Verify Your Coverage
  3. Gather Required Documentation
  4. Submit Your Prior Authorization Request
  5. Follow-Up and Tracking
  6. Typical Approval Timelines
  7. If You Need to Provide More Information
  8. If Your Request is Denied
  9. Renewal and Re-Authorization
  10. Quick Reference Checklist
  11. FAQ

What This Guide Covers

This comprehensive guide helps patients with epidermolysis bullosa (EB) and their healthcare providers navigate Humana's prior authorization process for Filsuvez in Washington state. You'll learn exactly what documentation is needed, how to submit requests efficiently, and what to do if coverage is initially denied.

Who this helps:

  • Patients with junctional or dystrophic EB seeking Filsuvez coverage
  • Healthcare providers submitting prior authorization requests
  • Caregivers navigating the appeals process

Expected outcomes: With complete documentation, Humana's PA denial rate is only ~3.5%—among the lowest of major insurers. Most approvals come within 1-2 business days when submitted electronically.

Before You Start: Verify Your Coverage

Confirm Your Plan Type

Filsuvez requires prior authorization across all Humana Medicare Advantage plans in Washington. Humana offers 18 Medicare Advantage plans in the state, including HMO, PPO, and D-SNP options in counties like King, Pierce, and Spokane.

Check Formulary Status

Filsuvez falls under Humana's specialty pharmacy network as a high-cost topical medication. Verify your specific plan's formulary tier and coverage details using Humana's Medicare drug list tool.

Pharmacy vs. Medical Benefit

Filsuvez is covered under Medicare Part D (pharmacy benefit) as a self-administered topical medication, not Part B medical benefit. This means it's subject to your plan's prescription drug coverage rules and the 2026 Part D out-of-pocket maximum of $2,100.

Gather Required Documentation

Essential Requirements

Requirement Details Documentation Needed
Diagnosis Confirmation Confirmed dystrophic (Q81.2) or junctional EB (Q81.1) Genetic testing results showing specific mutations
Patient Age ≥6 months old Birth certificate or medical records
Wound Criteria Partial-thickness wounds 10-50 cm² present ≥3 weeks Clinical photos with measurements, wound assessments
Prior Therapy Failures Standard wound care trials or alternatives Treatment records showing failures/intolerances
Specialist Prescription Dermatologist or EB specialist Prescription with clinical rationale

Genetic Testing Requirements

For dystrophic EB: COL7A1 gene mutations confirmed via genetic testing
For junctional EB: LAMA3, LAMB3, or LAMC2 gene mutations

Note: Genetic confirmation is mandatory—clinical diagnosis alone typically results in denial.

Clinical Documentation Checklist

  • Recent wound photographs with ruler for size reference
  • Wound assessment notes documenting size, depth, and healing progress
  • Prior treatment history (dressings, topicals, systemic therapies)
  • Documentation of treatment failures or intolerances
  • Current medication list and contraindications
  • Specialist consultation notes

Submit Your Prior Authorization Request

Step-by-Step Submission Process

Step 1: Access the PA Form (Healthcare Provider)

Step 2: Complete Required Sections

  • Patient demographics and insurance information
  • ICD-10 codes: Q81.1 (junctional EB) or Q81.2 (dystrophic EB)
  • Detailed medical necessity letter
  • Prior treatment documentation
  • Wound measurements and photos

Step 3: Submit Electronically (Fastest Option)

  • Electronic submission via provider portal: 95% responded in 1 business day
  • Alternative: Fax or phone submission (slower processing)
  • Include all supporting documentation in initial submission
Tip: Electronic submission through the provider portal is fastest and provides automatic tracking.

Medical Necessity Letter Components

Your healthcare provider should include:

  • Specific EB subtype with genetic confirmation
  • Current wound characteristics (size, location, duration)
  • Previous treatment failures with specific examples
  • Clinical rationale for Filsuvez therapy
  • Expected treatment duration and monitoring plan

Follow-Up and Tracking

When to Check Status

  • Day 3: If no response to electronic submission
  • Day 7: For fax/phone submissions
  • Day 14: If additional information was requested

Sample Phone Script for Patients

"Hi, I'm calling to check the status of a prior authorization request for Filsuvez submitted by Dr. [Name] on [date]. My member ID is [number] and the reference number is [if available]. Can you tell me the current status and if any additional information is needed?"

What to Document

  • Date and time of each call
  • Representative name and reference numbers
  • Any additional requirements mentioned
  • Expected decision timeline

Counterforce Health helps patients and providers streamline this process by automatically tracking prior authorization deadlines and generating targeted appeals when denials occur, turning insurance obstacles into successful approvals through evidence-based advocacy.

Typical Approval Timelines

Standard Processing Times

  • Electronic submission: 1-2 business days (95% response rate)
  • Fax/phone submission: 5-7 business days
  • Standard PA decision: 30 days maximum (Medicare Part C requirement)
  • Expedited review: 72 hours (with physician certification of urgent need)

What Speeds Approval

  • Complete genetic testing documentation
  • Clear wound photography with measurements
  • Detailed prior treatment failure records
  • Electronic submission via provider portal

What Slows Approval

  • Missing genetic confirmation
  • Incomplete prior therapy documentation
  • Unclear wound measurements or photos
  • Submission via fax without tracking

If You Need to Provide More Information

Common Information Requests

  • Additional wound photographs from different angles
  • More detailed genetic testing reports
  • Clarification of prior treatment durations
  • Specialist consultation notes

Response Timeline

You typically have 14 days to provide additional information before the request is considered incomplete.

Handling Medical Necessity Questions

If Humana questions medical necessity, ensure your provider includes:

  • FDA approval data for Filsuvez in EB (approved December 2024)
  • Clinical trial evidence showing 41.3% complete wound closure vs. 28.9% placebo
  • Specific wound characteristics that align with FDA labeling
  • Clear documentation that standard care has been insufficient

If Your Request is Denied

Common Denial Reasons and Solutions

Denial Reason Solution Timeline
Missing genetic confirmation Submit complete genetic testing results File appeal within 65 days
Insufficient prior therapy trials Document specific failures with dates/outcomes Same
Unclear wound documentation Provide standardized wound photos with measurements Same
Non-formulary status Request formulary exception with medical necessity Same

Appeals Process in Washington

Internal Appeals (Redetermination)

  • Deadline: 65 days from denial notice
  • Submission: Via Humana member portal, mail, or fax
  • Timeline: 7 days standard, 72 hours expedited
  • Required: Denial letter, new documentation, medical necessity letter

External Review (Washington State)

Washington Advantage: The state's external review process is particularly strong, with independent medical experts reviewing denials. Contact the OIC Consumer Advocacy line at 1-800-562-6900 for assistance.

Peer-to-Peer Review Request

If denied, request a peer-to-peer review where your specialist can discuss the case directly with Humana's medical director. This often resolves complex cases faster than formal appeals.

Renewal and Re-Authorization

When to Renew

  • Initial approval: Typically 3-6 months
  • Renewal timeline: Submit 30 days before expiration
  • Required documentation: Progress notes, wound photos showing improvement, ongoing specialist care

What to Include in Renewals

  • Updated wound assessments with measurements
  • Documentation of clinical improvement or stabilization
  • Continued medical necessity from specialist
  • Any changes in treatment plan or dosing

Quick Reference Checklist

Before Starting:

  • Verify Humana Medicare Advantage coverage
  • Confirm in-network dermatologist/EB specialist
  • Check formulary status for your specific plan

Required Documentation:

  • Genetic testing results (COL7A1, LAMA3/LAMB3/LAMC2)
  • ICD-10 codes (Q81.1 or Q81.2)
  • Wound photos with measurements
  • Prior treatment failure documentation
  • Medical necessity letter from specialist

Submission:

  • Submit electronically via provider portal (fastest)
  • Include all documents in initial submission
  • Document reference numbers and submission date

If Denied:

  • Review denial reason carefully
  • File internal appeal within 65 days
  • Consider peer-to-peer review
  • Prepare for external review if needed (180-day deadline)

FAQ

How long does Humana prior authorization take for Filsuvez in Washington? Electronic submissions typically receive responses within 1-2 business days. Standard processing can take up to 30 days, but most decisions come much faster with complete documentation.

What if Filsuvez is non-formulary on my plan? You can request a formulary exception based on medical necessity. Include documentation that formulary alternatives are inappropriate for your specific EB subtype.

Can I request expedited approval? Yes, if delay would jeopardize your health. Your physician must certify the urgent need, and Humana must respond within 72 hours.

What costs should I expect with approval? Costs depend on your plan's formulary tier. With GoodRx showing retail prices around $27,631, most patients will reach their Part D out-of-pocket maximum ($2,100 in 2026) quickly.

Does step therapy apply to Filsuvez? Step therapy requirements vary by plan. Most require documentation of failed standard wound care before approving Filsuvez, but specific EB medications may not have step therapy requirements.

What if I've tried treatments outside Washington? Prior treatment history from other states is valid. Ensure you have complete documentation of treatments tried and their outcomes, regardless of where they were attempted.

This guide provides educational information and should not be considered medical advice. Always consult with your healthcare provider about treatment decisions. For personalized assistance with insurance appeals in Washington, contact the Office of the Insurance Commissioner at 1-800-562-6900.

About Counterforce Health: Counterforce Health specializes in turning insurance denials into successful approvals for patients needing specialty medications. Our platform analyzes denial letters and creates targeted, evidence-backed appeals that align with each payer's specific requirements, helping patients access life-changing treatments like Filsuvez more quickly and effectively.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.